tenk.fyi

SELLAS Life Sciences Group, Inc.

SLSNasdaq· Pharmaceutical Preparations

Price History

Revenue

-

Net Income

-$30.9M

17.3% YoY

EPS

$-0.50

62.7% YoY

Cash

$13.9M

448.9% YoY

FY 2024 · As of 2024-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro